composite score when evaluating distress of animal models for gastrointestinal diseases. Sci Rep 13, 2605 (2023). Maria Reiber, Lara von Schumann, Verena Buchecker, Lena Boldt, Peter Gass, André Bleich, [...] überwacht, gemessen und kontextualisiert werden? Im Rahmen der von der DFG-geförderten Forschungsgruppe FOR2591 Severity Assessment [ www.severity-assessment.de ] entwickeln wir Lösungen, Algorithmen und Verfahren [...] (PVS) greift in diesem translationalen Projekt die Idee eines Fusionsscores auf und wendet ihn auf humane klinische Daten an. Ziel des Projekts ist es, eine automatisierte Überwachung des Belastungszustands

Bioethics Open Research 1:4 Katzer M, Salloch S, Schindler C, Mertz M (2023) Ethical requirements for human challenge studies: a systematic review of reasons . Clinical Pharmacology & Therapeutics 114:1209-1219 [...] Inthorn J, Haltaufderheide J (2022) How to derive ethically appropriate recommendations for action? A methodology for applied ethics . Medicine, Health Care and Philosophy 26:175-184 Kühlmeyer K, Mertz M [...] J, Kremling A, Schleidgen S, Inthorn J (2022) Empirical research and recommendations for moral action: A plea for the transparent reporting of bridge principles in public health research . Public Health

related to poor survival in human hepatocellular carcinoma. World J Gastroenterol 2017; 23(9): 1568-1575 Anwar SL , Wulaningsih W, Lehmann U : Transposable Elements in Human Cancer: Causes and Consequences [...] Augustin D, Aktas B, Forstbauer H, Tio J, von Schumann R, Liedtke C, Grischke EM, Schumacher J, Wuerstlein R, Kreipe HH , Nitz UA: De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2 [...] Splenocyte Infusion and Whole-Body Irradiation for Induction of Peripheral Tolerance in Porcine Lung Transplantation: Modifications of the Preconditioning Regime for Improved Clinical Feasibility. Transplant

Dipl.-Biochem., Paul-Ehrlich-Institut, Langen Dr. rer. nat Jessica Rößler, Eppendorf Dr. Mathewos Tessema, PhD, Lung Cancer Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA [...] Schwerpunktprofessur Molekularpathologie Kontakt: Prof. Dr. Ulrich Lehmann Institut für Pathologie Medizinische Hochschule Hannover Carl-Neuberg-Str. 1 D-30625 Hannover Tel.: +49-(0)511-532-4475 Fax: [...] der MHH 2008 wurde ich Ende 2009 zum ordentlichen Universitätsprofessor für Molekularpathologie am Institut für Pathologie der Medizinischen Hochschule Hannover berufen. In dieser Funktion leite ich eine

(2017). Inner tegument proteins of Herpes Simplex Virus are sufficient for intracellular capsid motility in neurons but not for axonal targeting. PLoS Pathog 13, e1006813. 14. Buchmann, B., Dohner, K [...] Wedemeyer, H., Ciesek, S., and von Hahn, T. (2017). A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection. Antiviral Res 141, 116-123. 15. Budida [...] Rovis, T., Jonjic, S., and Messerle, M. (2016). The Essential Human Cytomegalovirus Proteins pUL77 and pUL93 Are Structural Components Necessary for Viral Genome Encapsidation. J Virol 90, 5860-5875. 25. Doll

Dr. med. Thomas F. Schulz Klinik / Institut: Institut für Virologie, MHH Wir wollen breit neutralisierende, d.h. gegen verschiedene Coronaviren schützende, humane monoklonale Antikörper als rekombinante [...] idaten gegen SARS-CoV-2 Projektleitung: Prof. Dr. Reinhold Förster Klinik / Institut: Institut für Immunologie Das Institut für Immunologie testet in Kooperation mit der Ludwig-Maximilians-Universität [...] Interface cultures of human primary distal respiratory epithelial for in vitro modelling of SARS-CoV2 infection Projektleitung: Prof. Ulrich Martin, Dr. Ruth Olmer Klinik / Institut: HTTG/ LEBAO Eine Infektion

therapy. Final exam June 2020. Michelangelo Marasco ITALY Supervisor: Prof. Dr. Teresa Carlomagno, Institute for Organic Chemistry / BMWZ, Leibniz Universität Hannover, Project: Structural basis of the activation [...] : Prof. Dr. Christine Falk, IFB-Tx, OE 8889, Project: T and NK cell-mediated immune responses of human lung transplant recipients in vivo - impact on the development of transplant arteriosclerosis. Final [...] Dr. Hildegard Büning, Experimental Hematology, OE 6960, Project: Targeting HIV Integration sites for long term remission and cure. Final exam June 2020. Muhammad Faisal PAKISTAN Supervisor: Prof. Dr.

JH; for the European Society of Pathology Task Force on Quality Assurance in Molecular Pathology and the Royal College of Pathologists: Guidance for laboratories performing molecular pathology for cancer [...] Bröcker V , Klempnauer J, Winkler M, Tiede A: Recombinant human antithrombin prevents xenogenic activation of hemostasis in a model of pig-to-human kidney transplantation. Xenotransplantation 2014; 21(4): [...] Sundarasetty BS, Witte T, Ganser A, Stripecke R: Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation. J Immunol 2014; 192(10): 4636-4647

Björn Zorn (2012) MPI for Chemical Energy Conversion, Mülheim Dr. Giulia Falorsi (2016) PhD at Universita’ degli Studi Di Siena, Italy Dr. Dmitry Soloviov (2016) Joint Institute for Nuclear Research, Dubna [...] Hannover, Germany Dr. Johannes Greve (2018-2021 Dr. rer. nat. in the Manstein group) Group leader, Institute for Biophysical Chemistry, MHH, Hannover, Germany Postdoctoral Research Assistants Postdoctoral Research [...] at the Max Planck Institute of Biochemistry, Munich, Germany Prof. Dr. Matthias Preller (2009-2012 Dr. rer. nat. in the Manstein group) Professor of Structural Bioinformatics, Centre for Structural Systems

asked by this panel. For case reports: The Joanna Briggs Institute Critical Appraisal Tool for case reports For case series: The Joanna Briggs Institute Critical Appraisal Tool for case series Tools will [...] / RATIONALE In 2013 the AAN consensus criteria for diagnosis of PML were published. This was a landmark achievement that established two approaches for diagnosis: the first based on characteristic hi [...] of JCV-related disease. Further, the development of robust pharmacovigilance programs for patients at highest risk for PML have taught to detect the earliest, even preclinical stages of disease. Taken together